Sort
261,768 grants matching “gene therapy”
Anatomic Pathology Residency Program
$1,403,017John Oberholtzer · Division Of Basic Sciences - Nci · ZIE · FY2015 · CA
Leukemia Signatures for Risk Classification & Targeting
$1,402,928Cheryl L Willman · University Of New Mexico · U01 · FY2008 · CA
alpha-Synuclein and LRRK2 in the Pathogenesis of Parkinson's Disease
$1,402,795Jie Shen · Brigham And Women'S Hospital · P50 · FY2019 · NS
alpha-Synuclein and LRRK2 in the Pathogenesis of Parkinson's Disease
$1,402,795Jie Shen · Brigham And Women'S Hospital · P50 · FY2018 · NS
alpha-Synuclein and LRRK2 in the Pathogenesis of Parkinson's Disease
$1,402,794Jie Shen · Brigham And Women'S Hospital · P50 · FY2017 · NS
Center of Research Translation on the Osteoimmunology of Bone Infection (CoRTOBI)
$1,402,705Edward M Schwarz · University Of Rochester · P50 · FY2022 · AR
Mechanisms of Nucleic Acid Enzymes - Pol Beta, HIV-1 Reverse Transcriptase and Mammalian Base Repair Enzymes
$1,402,557Samuel H Wilson · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES
Comprehensive multimodal analysis of patients with neuroimmunological diseases
$1,402,526Bibiana Bielekova · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Circulating levels of Persistent Organic Pollutants and Subclinical Atherosclerosis progression in Postmenopausal women
$1,402,486Roksana Karim · University Of Southern California · R01 · FY2025 · ES
Exploiting DNA Replicative Stress for Novel Small Cell Lung Cancer Therapies
$1,402,170Anish Thomas · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Intracellular In vivo Imaging
$1,402,125Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Development of a SYF2 antisense oligonucleotide treatment for ALS and FTD
$1,402,110Samuel V Alworth · Acurastem, Inc. · R44 · FY2024 · AG
Retinal disease models for translational photoreceptor replacement
$1,401,827John H Wolfe · Children'S Hosp Of Philadelphia · U24 · FY2018 · EY
Enhancement of hematopoietic stem cell mobilization and engraftment
$1,401,796Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
X-Linked Mental Retardation-Linkage
$1,401,778Greenwood Genetic Center · R01 · FY2003 · HD
Mechanisms of pathogenesis in patient derived organoid models of prostate cancer
$1,401,521Kathleen Kelly · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA
Wellstone Muscular Dystrophy Specialized Research Center (Seattle)
$1,401,023Jeffrey S Chamberlain · University Of Washington · P50 · FY2019 · AR
The connection of innate and adaptive anti-cancer immunity
$1,400,831John Greiner · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Emerging respiratory viruses - pathogenesis and countermeasures
$1,400,690Emmie De Wit · National Institute Of Allergy And Infectious Diseases · ZIA · FY2022 · AI
Brain-Wide Quantification of Blood-Brain Barrier Penetrating Antibody Therapeutics
$1,400,651Damian G. Wheeler · Translucence Biosystems, Inc. · R44 · FY2025 · AG
Improving drug design to eliminate side effects: From computational to animal models
$1,400,649C. Denise Okafor · Pennsylvania State University, The · DP2 · FY2022 · GM
Uncovering mechanisms of protection from Alzheimer's disease in CHIP using human cohorts and biosamples
$1,400,625Siddhartha Jaiswal · Stanford University · R01 · FY2025 · AG
Rational approaches to melanoma therapy
$1,400,393Meenhard Herlyn · Wistar Institute · U54 · FY2020 · CA
Identification of Genes Involved in Major Mood Disorders
$1,400,314Francis J McMahon · National Institute Of Mental Health · ZIA · FY2017 · MH
Proteins From Hereditary Eye Diseases: In silico and Experimental Studies
$1,400,265Yuri Sergeev · National Eye Institute · ZIA · FY2022 · EY